Levoketoconazole and Indinavir: Interaction Details

Brand names
Indinavir
Crixivan
Levoketoconazole
Recorlev
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

Indinavir

Brand name
  • Crixivan

We don't have a drug information page for Indinavir yet. Have a question about Indinavir? Ask a pharmacist, free →

What Happens When You Take Levoketoconazole With Indinavir

What can happen when they are taken together (rated Contraindicated)

Increased levoketoconazole exposure, increased risk of levoketoconazole-related adverse effects, an increased exposure and an increase risk of CYP3A4 substrate-related adverse effects

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Levoketoconazole must not be given together with sensitive CYP3A4 substrates, as this combination is . Because levoketoconazole inhibits CYP3A4, using it at the same time as a sensitive CYP3A4 substrate may raise indinavir exposure and could heighten the likelihood of adverse reactions.

A strong CYP3A4 taken with levoketoconazole may likewise raise levoketoconazole exposure, which may increase the risk of adverse reactions attributable to levoketoconazole. When cannot be avoided, the sensitive CYP3A4 substrate should not be used beginning 2 weeks before treatment with levoketoconazole and throughout the treatment period.1

The Levoketoconazole and Indinavir Interaction, Explained

These two medicines should not be used together. Both are broken down by the same liver enzyme (), and each can slow that enzyme down. Indinavir (an HIV medicine) and levoketoconazole (used for high cortisol in Cushing's syndrome) can each raise the other's levels in your body. Higher levels may mean more side effects from either medicine. This is based on how the drugs work rather than on large studies in people, but the label still treats it as a serious concern.

Please don't change or stop anything on your own. Talk with your pharmacist or doctor, who can review your options and decide on the safest plan for you.

(labeling), evidence theoretical. Levoketoconazole is a and a CYP3A4 . Indinavir is a sensitive CYP3A4 substrate and a strong CYP3A4 inhibitor.

  • Direction: bidirectional. Indinavir may increase levoketoconazole exposure (reduced CYP3A4 ), raising levoketoconazole-related adverse effects. Levoketoconazole may increase indinavir exposure and indinavir-related toxicity.
  • Onset: unspecified.
  • Management: avoid . If it is unavoidable, avoid the sensitive CYP3A4 substrate from 2 weeks before and during levoketoconazole treatment. Consider an alternative antiretroviral and individualize therapy with close monitoring.

See the 1 reference behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Levoketoconazole and Indinavir Interact

The likely mechanism

of -mediated of levoketoconazole; inhibition of CYP3A4-mediated metabolism by levoketoconazole

How Drug Interactions Work Six short figures, about a minute: how one drug can raise or lower another’s level, or add to or cancel its effect. See how it works 

How to Manage the Levoketoconazole and Indinavir Interaction

Your care team will usually try to avoid using these two medicines together. Here is what that may look like:

  • Your prescriber may choose a different medicine in place of indinavir or levoketoconazole.
  • If using both is truly required, the label advises avoiding the sensitive medicine (here, indinavir) starting 2 weeks before and during levoketoconazole treatment. Your team may also monitor you more closely and tailor your plan.

What you can do: take your medicines exactly as prescribed until your care team tells you otherwise, and make sure your pharmacist and prescribers know about everything you take. Report any new or unusual symptoms promptly.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Levoketoconazole or Indinavir need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

1 report from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Prescribing information: RECORLEV oral tablets, levoketoconazole oral tablets

    When levoketoconazole 400 mg once daily was given together with felodipine (a sensitive ), felodipine and rose by 1007% and 937%, respectively, relative to felodipine given alone (N=14).1

Levoketoconazole and Indinavir: Common Questions

How serious is the Levoketoconazole and Indinavir interaction?

It is rated . These should generally not be used together.

How is the Levoketoconazole and Indinavir interaction managed?

Your care team will usually try to avoid using these two medicines together. Here is what that may look like: Your prescriber may choose a different medicine in place of indinavir or levoketoconazole. If using both is truly required, the label advises avoiding the sensitive medicine (here, indinavir) starting 2 weeks before and during levoketoconazole treatment. Your team may also monitor y… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

Ask About the Levoketoconazole and Indinavir Interaction

Ask in your own words about taking Levoketoconazole and Indinavir together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (1)

  1. Product Information: RECORLEV(R) oral tablets, levoketoconazole oral tablets. Xeris Pharmaceuticals Inc (per FDA), Chicago, IL, 2023. DailyMed
Was this write-up helpful?

Other Serious Interactions of Levoketoconazole and Indinavir

Also serious with Indinavir

Also serious with Levoketoconazole

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Indinavir

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together. This interaction.
  • Major Potentially serious — often needs a change or close monitoring.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.